Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)

ClinicalTrials.gov ID: NCT01124786

Public ClinicalTrials.gov record NCT01124786. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 With Gemcitabine as First-Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether CO-1.01 is safe and effective in the treatment of patients with metastatic pancreatic cancer and low hENT1 expression compared with gemcitabine.

Study identification

NCT ID
NCT01124786
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Clovis Oncology, Inc.
Industry
Enrollment
367 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2010 (Type not available)
Primary completion
Nov 2012 (Actual)
Completion
Jun 2013 (Actual)
Last update posted
Apr 17, 2014

2010 – 2013

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Arizona Center for Hematology Oncology Glendale Arizona 85306 —
Wilshire Oncology Medical Group, Inc. Corona California 92879 —
White Memorial Medical Center Los Angeles California 90033 —
Cancer Care Institute Los Angeles California 90036 —
Newport Cancer Care Medical Newport Beach California 92660 —
Hematology Oncology Associates Oakland California 94609 —
Sharp Clinical Oncology Research San Diego California 92123 —
Rocky Mountain Cancer Centers Denver Colorado 80218 —
Hartford Hospital Clinical Research Hartford Connecticut 06102 —
Oncology Associates of Bridgeport Trumbull Connecticut 06611 —
Annapolis Oncology Center Annapolis Maryland 21401 —
Virginia Piper Cancer Institute Minneapolis Minnesota 55407 —
The Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
New Mexico Cancer Care Alliance Albuquerque New Mexico 87109 —
Arena Oncology Associates, PC Lake Success New York 11042 —
Bend Memorial Clinic Bend Oregon 97701 —
Cancer Center of the Carolinas Greenville South Carolina 29605 —
Cancer Specialists of South Texas, P.A. Corpus Christi Texas 78412 —
Valley Cancer Associates Harlingen Texas 78550 —
South Texas Oncology and Hematology, PA San Antonio Texas 78229 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01124786, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2014 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01124786 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →